|
Back to products
Browse products
Approved anticancer agents
Anticancer agents in trials
Anticancer agents
in preclinical trials
Anticancer molecular libraries
Other drug agents
Drug intermediates
Bio-reagents and biochemicals
|
MedKoo product information:
LDK378
Description of LDK378:
Current developer:
Novartis Pharmaceuticals.
|
MedKoo Code#: 205511
|
|
Name: LDK378
|
|
CAS#:
Synonym: LDK-378; LDK378;
IUPAC/Chemical name:
|
|
Chemical structure
|
Theoretical analysis
|
|
|
|
|
Availability and price:
This agent is
not in stock, may be available through custom synthesis.
To inquire quotation and lead time or to ask questions, please send email to
sales@medkoo.com to describe your needs. A representative
will respond your email shortly. We offer big discount for orders of bulk quantities.
|
|
Information about this agent
|
LDK378 is a adenotriphosphate (ATP)-competitive
inhibitor of ALK activity.
|
Contact MedKoo:
Email:
sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|